Boill Healthcare Holdings Past Earnings Performance
Past criteria checks 0/6
Boill Healthcare Holdings has been growing earnings at an average annual rate of 7.6%, while the Real Estate industry saw earnings declining at 1% annually. Revenues have been growing at an average rate of 11.9% per year.
Key information
7.6%
Earnings growth rate
19.5%
EPS growth rate
Real Estate Industry Growth | 2.8% |
Revenue growth rate | 11.9% |
Return on equity | n/a |
Net Margin | -41.6% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 89% Share Price Slump
Jun 03The Price Is Right For Boill Healthcare Holdings Limited (HKG:1246) Even After Diving 26%
Apr 18Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 33% Share Price Slump
Feb 05Boill Healthcare Holdings (HKG:1246) Has Debt But No Earnings; Should You Worry?
Jul 31Lacklustre Performance Is Driving Boill Healthcare Holdings Limited's (HKG:1246) Low P/S
Apr 18There's Been No Shortage Of Growth Recently For Boill Healthcare Holdings' (HKG:1246) Returns On Capital
Jul 22Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?
Jul 13Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?
Mar 21Have Insiders Been Buying Boill Healthcare Holdings Limited (HKG:1246) Shares This Year?
Jan 27Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?
Dec 05Revenue & Expenses Breakdown
How Boill Healthcare Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 285 | -119 | 48 | 0 |
30 Sep 23 | 355 | -203 | 37 | 0 |
30 Jun 23 | 352 | -213 | 33 | 0 |
31 Mar 23 | 348 | -224 | 30 | 0 |
30 Sep 22 | 430 | -30 | 24 | 0 |
30 Jun 22 | 717 | -21 | 36 | 0 |
31 Mar 22 | 1,005 | -12 | 47 | 0 |
31 Dec 21 | 1,028 | -299 | 84 | 0 |
30 Sep 21 | 1,039 | -81 | 89 | 0 |
30 Jun 21 | 628 | -112 | 86 | 0 |
31 Mar 21 | 217 | -142 | 84 | 0 |
31 Dec 20 | 139 | -172 | 76 | 0 |
30 Sep 20 | 61 | -201 | 68 | 0 |
30 Jun 20 | 84 | -195 | 63 | 0 |
31 Mar 20 | 106 | -189 | 57 | 0 |
31 Dec 19 | 227 | -185 | 59 | 0 |
30 Sep 19 | 347 | -181 | 61 | 0 |
30 Jun 19 | 384 | -190 | 77 | 0 |
31 Mar 19 | 420 | -200 | 93 | 0 |
31 Dec 18 | 572 | -232 | 105 | 0 |
30 Sep 18 | 724 | -237 | 118 | 0 |
30 Jun 18 | 731 | -225 | 123 | 0 |
31 Mar 18 | 738 | -214 | 128 | 0 |
31 Dec 17 | 616 | -298 | 122 | 0 |
30 Sep 17 | 459 | -412 | 98 | 0 |
30 Jun 17 | 473 | -491 | 94 | 0 |
31 Mar 17 | 487 | -570 | 89 | 0 |
31 Dec 16 | 492 | -450 | 102 | 0 |
30 Sep 16 | 485 | -327 | 110 | 0 |
30 Jun 16 | 509 | -260 | 99 | 0 |
31 Mar 16 | 532 | -193 | 87 | 0 |
31 Dec 15 | 512 | -113 | 80 | 0 |
30 Sep 15 | 492 | -33 | 72 | 0 |
30 Jun 15 | 525 | 29 | 67 | 0 |
31 Mar 15 | 558 | 91 | 61 | 0 |
31 Dec 14 | 562 | 84 | 56 | 0 |
30 Sep 14 | 566 | 78 | 50 | 0 |
30 Jun 14 | 527 | 76 | 49 | 0 |
31 Mar 14 | 487 | 73 | 47 | 0 |
31 Dec 13 | 441 | 69 | 37 | 0 |
Quality Earnings: 1246 is currently unprofitable.
Growing Profit Margin: 1246 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1246 is unprofitable, but has reduced losses over the past 5 years at a rate of 7.6% per year.
Accelerating Growth: Unable to compare 1246's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1246 is unprofitable, making it difficult to compare its past year earnings growth to the Real Estate industry (-11.2%).
Return on Equity
High ROE: 1246's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/10/21 13:05 |
End of Day Share Price | 2024/07/24 00:00 |
Earnings | 2024/03/31 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Boill Healthcare Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|